Long-term treatment with idebenone and riboflavin in a patient with MELAS
被引:0
作者:
A. Napolitano
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
A. Napolitano
S. Salvetti
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
S. Salvetti
M. Vista
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
M. Vista
V. Lombardi
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
V. Lombardi
G. Siciliano
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
G. Siciliano
C. Giraldi
论文数: 0引用数: 0
h-index: 0
机构:Division of Neurology,
C. Giraldi
机构:
[1] Division of Neurology,
[2] Campo di Marte Hospital,undefined
[3] I-55100 Lucca,undefined
[4] Italy,undefined
[5] Department of Neuroscience,undefined
[6] University of Pisa,undefined
[7] Pisa,undefined
[8] Italy,undefined
来源:
Neurological Sciences
|
2000年
/
21卷
关键词:
Key words MELAS;
Idebenone;
Riboflavin;
Therapy;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
We report a patient with MELAS treated for 24 months with idebenone and riboflavin, during which no stroke-like episodes occured. Moreover neurological symptoms clearly improved, and a recovery of brain MRI and EEG abnormalities was observed. We conclude that the combined treatment with idebenone and riboflavin may restore the metabolic impairment in MELAS, possibly improving the long-term prognosis in these patients.